Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Rothman

Showing results (281-290 of 532) with videos related to

Pageof 54
Sort By:
Psychopharmacology|September 11, 2017
Cocaine-like discriminative stimulus effects of "norepinephrine-preferring" monoamine releasers: time course and interaction studies in rhesus monkeysStephen J Kohut, David S Jacobs, Richard B Rothman, et al.
Neuropeptides|January 1, 1988
Tritiated-6-beta-fluoro-6-desoxy-oxymorphone ([3H]FOXY): a new ligand and photoaffinity probe for the mu opioid receptorsR B Rothman, V Bykov, K C Rice, et al.
Peptides|July 1, 1992
A study of the effect of the irreversible delta receptor antagonist [D-Ala2,Leu5,Cys6]-enkephalin on delta cx and delta ncx opioid binding sites in vitro and in vivoR B Rothman, V Bykov, A E Jacobson, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1988
beta-FNA binds irreversibly to the opiate receptor complex: in vivo and in vitro evidenceR B Rothman, J B Long, V Bykov, et al.
Life Sciences|January 25, 2011
Perinatal lead exposure alters locomotion induced by amphetamine analogs in ratsP Shane Clifford, Nigel Hart, Richard B Rothman, et al.
Synapse (New York, N.Y.)|February 25, 2005
Noradrenergic and dopaminergic effects of (+)-amphetamine-like stimulants in the baboon Papio anubisMohab Alexander, Richard B Rothman, Michael H Baumann, et al.
Peptides|November 1, 1993
Selective labeling of kappa 2 opioid receptors in rat brain by [125I]IOXY: interaction of opioid peptides and other drugs with multiple kappa 2a binding sitesQ Ni, H Xu, J S Partilla, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 22, 2013
Nonlinear pharmacokinetics of (+/-)3,4-methylenedioxymethamphetamine (MDMA) and its pharmacodynamic consequences in the ratMarta Concheiro, Michael H Baumann, Karl B Scheidweiler, et al.
Psychopharmacology|May 8, 2014
Interaction of psychoactive tryptamines with biogenic amine transporters and serotonin receptor subtypesBruce E Blough, Antonio Landavazo, Ann M Decker, et al.
Molecular Pharmacology|March 1, 1985
A quantitative study of [3H]D-Ala2-D-Leu5-enkephalin binding to rat brain membranes. Evidence that oxymorphone is a noncompetitive inhibitor of the lower affinity delta-binding siteR B Rothman, W D Bowen, M Herkenham, et al.
Pageof 54

Showing results (281-290 of 532) with videos related to

Sort By:
Pageof 54
Psychopharmacology|September 11, 2017
Cocaine-like discriminative stimulus effects of "norepinephrine-preferring" monoamine releasers: time course and interaction studies in rhesus monkeysStephen J Kohut, David S Jacobs, Richard B Rothman, et al.
Neuropeptides|January 1, 1988
Tritiated-6-beta-fluoro-6-desoxy-oxymorphone ([3H]FOXY): a new ligand and photoaffinity probe for the mu opioid receptorsR B Rothman, V Bykov, K C Rice, et al.
Peptides|July 1, 1992
A study of the effect of the irreversible delta receptor antagonist [D-Ala2,Leu5,Cys6]-enkephalin on delta cx and delta ncx opioid binding sites in vitro and in vivoR B Rothman, V Bykov, A E Jacobson, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1988
beta-FNA binds irreversibly to the opiate receptor complex: in vivo and in vitro evidenceR B Rothman, J B Long, V Bykov, et al.
Life Sciences|January 25, 2011
Perinatal lead exposure alters locomotion induced by amphetamine analogs in ratsP Shane Clifford, Nigel Hart, Richard B Rothman, et al.
Synapse (New York, N.Y.)|February 25, 2005
Noradrenergic and dopaminergic effects of (+)-amphetamine-like stimulants in the baboon Papio anubisMohab Alexander, Richard B Rothman, Michael H Baumann, et al.
Peptides|November 1, 1993
Selective labeling of kappa 2 opioid receptors in rat brain by [125I]IOXY: interaction of opioid peptides and other drugs with multiple kappa 2a binding sitesQ Ni, H Xu, J S Partilla, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 22, 2013
Nonlinear pharmacokinetics of (+/-)3,4-methylenedioxymethamphetamine (MDMA) and its pharmacodynamic consequences in the ratMarta Concheiro, Michael H Baumann, Karl B Scheidweiler, et al.
Psychopharmacology|May 8, 2014
Interaction of psychoactive tryptamines with biogenic amine transporters and serotonin receptor subtypesBruce E Blough, Antonio Landavazo, Ann M Decker, et al.
Molecular Pharmacology|March 1, 1985
A quantitative study of [3H]D-Ala2-D-Leu5-enkephalin binding to rat brain membranes. Evidence that oxymorphone is a noncompetitive inhibitor of the lower affinity delta-binding siteR B Rothman, W D Bowen, M Herkenham, et al.
Pageof 54